‘Female Viagra’ approved by FDA
The FDA have approved the first ever drug to treat low sexual desire in premenopausal women. Flibanserin – brand name Addyi – will be available from mid-October. …read more
The FDA have approved the first ever drug to treat low sexual desire in premenopausal women. Flibanserin – brand name Addyi – will be available from mid-October. …read more
For children with aggressive brain cancers called high-grade gliomas (HGG), the chances of survival are improved when surgery is successful in eliminating all visible cancer, reports a study in the… …read more
Seven million women a year in the developing world are treated in healthcare facilities for complications following unsafe abortion, finds a study published today (19 August) in BJOG: An… …read more
Main Finding(s): Non-Hispanic black women with endometrial cancer had worse outcomes than women in other racial/ethnic groups diagnosed with the same subtype of endometrial cancer and at the same… …read more
The manufacturer aims to have the drug available for sale starting October 17. FDA Approvals …read more
Scientists have identified a series of genes which appear to play an important role in the longer survival of women with ovarian cancer. …read more
UCI study first to tie low natal weight to biological, social factors 3 generations deepA woman’s weight at birth, education level and marital status pre-pregnancy can have repercussions for two… …read more
A study conducted by researchers at Hasbro Children’s Hospital, Boston Children’s Hospital, Fairfax (VA) County Public Schools and the University of Colorado School of Medicine has found that… …read more
A recent prospective study has found that a vaginal microbiome poor in Lactobacillus may be associated with an increased risk for premature delivery. Medscape Medical News …read more
New research indicates that use of oral contraceptives may provide benefits for women with inflammatory arthritis. …read more